Although up-regulation of PDIA3 was reported in breast cancer [34, 61] and hepatocellular carcinoma [62] tissues, to the best of our knowledge, it is the first time for detection of PDIA3 antibodies in plasma from PCa patients. Here, PDIA3 is linked to posterior cortical atrophy.